Table 2

MEA recommendations

ConditionRecommendations
TypeText
HyperlipidaemiaLow to moderate-intensity statinConsider low to moderate-intensity statin therapy due to diabetes and elevated cholesterol
Consider moderate-intensity statin therapy due to diabetes and elevated risk
Consider moderate-intensity statin therapy due to ASCVD (age>75)
Consider moderate-intensity statin therapy due to elevated risk
Moderate to high-intensity statinConsider moderate to high-intensity statin therapy due to ASCVD
Consider moderate to high-intensity statin therapy due to LDL ‚Č•190
Consider moderate to high-intensity statin therapy due to diabetes and elevated risk
Lifestyle modificationTherapeutic lifestyle modifications recommended due to elevated triglycerides and risk of pancreatitis
Fibrate/omega 3Fibrate and/or omega 3 therapy recommended due to elevated triglycerides and risk of pancreatitis
Well managedLipids are controlled on current medication
Atrial fibrillationNo anticoagulationNo anticoagulation therapy indicated due to CHA2DS2-VASc score=0
Initiate anticoagulationConsider anticoagulation therapy, if HAS-BLED score <3, due to CHA2DS2-VASc score=1
Consider anticoagulation therapy, if HAS-BLED score <3, due to CHA2DS2-VASc score 2 or greater
Well managedPatient on anticoagulant well managed according to guidelines for management of atrial fibrillation
Heart failureInitiate beta blockerConsider beta blocker due to heart failure
Initiate ACE inhibitor or ARBConsider ACE inhibitor or ARB due to heart failure
Titrate ACE inhibitor or ARBConsider increasing dose of ACE inhibitor or ARB to target dose for heart failure, monitor creatinine and potassium levels
Titrate beta blockerConsider increasing dose of beta blocker to target dose for heart failure
Titrate aldosterone blockerConsider increasing dose of aldosterone blocker to target dose for heart failure, monitor creatinine and potassium levels
Medication contraindicatedDiltiazem contraindicated because of heart failure
Verapamil contraindicated because of heart failure
Non-steroidal anti-inflammatory drugs contraindicated because of heart failure
Rosiglitazone contraindicated because of heart failure
Cilostazol contraindicated because of heart failure
Itraconazole contraindicated because of heart failure
Dronedarone contraindicated because of heart failure
Flecainide contraindicated because of heart failure
Propafenone contraindicated because of heart failure
Well managedPatient is on appropriate dose of beta blocker
Patient is on appropriate dose of ACE inhibitor or ARB
Patient is on appropriate dose of aldosterone blocker.
  • ARB,¬†angiotensin receptor blocker; ASCVD, atherosclerotic cardiovascular disease; LDL, low-density lipoprotein; MEA, MayoExpertAdvisor.